The European Medicines Agency

The European Medicines Agency is a public body in Amsterdam, Netherlands that has taken part in 18 EU-funded projects since 2009, receiving €2.1M in EU funding and leading 1 as coordinator.

EU funding received€2.1M
EU projects18
As coordinator1
Running now3
First EU project2009
Latest project2025
CountryNetherlands
EU registration (PIC)997654895
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are The European Medicines Agency's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.2M · 7 projects
  • Horizon Europe€752k · 4 projects
  • Horizon 2020€148k · 5 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project
  • EU4Health Programme (EU4H)€0 · 1 project

Projects

18 EU-funded projects, newest first. The European Medicines Agency led 1 of them as coordinator. Each links to the official record.

  • BRIDGEPartner

    Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €198ktheir share
  • RealiseDPartner

    Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €554ktheir share
  • EUPAHWAssociated partner

    European Partnership Animal health and Welfare

    Horizon Europe · 2024–2030 · Project on CORDIS ↗

  • M6ATCELLAssociated partner

    Exploiting fundamental insights of m6A methylation on CD8 T cell differentiation and function to boost medicinal T cell products

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

  • EHDS2 PilotPartner

    Pilot for a European Health Data Space on secondary use of health data

    EU4Health Programme (EU4H) · 2022–2024 · Project on the EU portal ↗

  • ALADDINAssociated partner

    Multi-stakeholder Education Alliance to Accelerate Drug Development for Children and Adolescent with Cancer (ALADDIN)

    Erasmus+ (ERASMUS+) · 2022–2025 · Project on the EU portal ↗

  • SISAQOL-IMIPartner

    Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €61ktheir share
  • PREMIERPartner

    Prioritisation and Risk Evaluation of Medicines in the EnviRonment

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €47ktheir share
  • ConcePTIONPartner

    Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €33ktheir share
  • STARSPartner

    Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

    €8ktheir share
  • ADAPT-SMARTPartner

    Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  • FLUCOPPartner

    Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection

    FP7 (2007 to 2013) · 2015–2020 · Project on CORDIS ↗

    €40ktheir share
  • WEB-RADRPartner

    Recognising Adverse Drug Reactions

    FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗

    €247ktheir share
  • GETREALPartner

    Incorporating real-life clinical data into drug development

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €118ktheir share
  • ADVANCEPartner

    Accelerated Development of Vaccine benefit-risk Collaboration in Europe

    FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗

    €219ktheir share
  • GRIPPartner

    Global Research in Paediatrics

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €151ktheir share
  • PROTECTCoordinator

    Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium

    FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗

    €396ktheir share
  • EU2PPartner

    European programme in Pharmacovigilance and Pharmacoepidemiology

    FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗

    €30ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • adverse drug reactions
  • cell biology
  • data mining
  • databases
  • drug discovery
  • drug safety
  • eHealth
  • ecosystems
  • enzymes
  • governance
  • influenza
  • obstetrics
  • oncology
  • paediatrics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime